RecallRadar

FDA Device recall Z-2994-2018

Diagnostica Stago STA N¿oplastine¿ CI, 10 ml vial

On 2018-09-19 the FDA classified a Class II recall of Diagnostica Stago STA N¿oplastine¿ CI, 10 ml vial by Diagnostica Stago, citing QC values outside of the assigned ranges (prolonged Prothrombin time / decreased PT %).

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-2994-2018
ClassificationClass II
Statusterminated
Initiated2018-07-24
Published2018-09-19
Last updated2026-09-13 11:54 UTC
CompanyDiagnostica Stago
DistributionUS

Product

Diagnostica Stago STA N¿oplastine¿ CI, 10 ml vial. In-Vitro Diagnostic for determination of the prothrombin time (PT) in plasma. REF: 00666 The STA¿ - N¿oplastine¿ CI kits provide reagents for the determination of the prothrombin time (PT) in plasma with STA-R¿, STA Compact¿ and STA Satellite¿. (In the USA this procedure has been assigned to the moderate complexity category per CLIA 1988 - CDC Analyte Code 4922; CDC Test System Codes 4677 and 4875).

Reason

QC values outside of the assigned ranges (prolonged Prothrombin time / decreased PT %)

Identifiers

code_info
Lot Number/Exp. Date/UDI 251426 2018-11-30 (01)03607450006667(11)161130(17)181130(10)251426(241)00666; 251763 2019-…Lot Number/Exp. Date/UDI 251426 2018-11-30 (01)03607450006667(11)161130(17)181130(10)251426(241)00666; 251763 2019-02-28 (01)03607450006667(11)170228(17)190228(10)251763(241)00666

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2994-2018%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.